Three Combined Treatments, a Novel HDAC Inhibitor OBP-801/YM753, 5-Fluorouracil, and Paclitaxel, Induce G2 Phase Arrest Through the p38 Pathway in Human Ovarian Cancer Cells.

Akiyama, Makoto; Sowa, Yoshihiro; Taniguchi, Tomoyuki; Watanabe, Motoki; Yogosawa, Shingo; Kitawaki, Jo; Sakai, Toshiyuki

Akiyama, Makoto; Sowa, Yoshihiro; Taniguchi, Tomoyuki; Watanabe, Motoki; Yogosawa, Shingo; Kitawaki, Jo; Sakai, Toshiyuki.

Oncol Res ; 25(8): 1245-1252, 2017 Sep 21.

Article in En | MEDLINE | ID: mdl-28117030

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/pharmacology; MAP Kinase Signaling System/drug effects; Ovarian Neoplasms/drug therapy; p38 Mitogen-Activated Protein Kinases/metabolism; Female; Fluorouracil/administration & dosage; G2 Phase/drug effects; Humans; Ovarian Neoplasms/enzymology; Ovarian Neoplasms/pathology; Paclitaxel/administration & dosage; Peptides, Cyclic/administration & dosage

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Antineoplastic Combined Chemotherapy Protocols / MAP Kinase Signaling System / P38 Mitogen-Activated Protein Kinases Limits: Female / Humans Language: En Journal: Oncol Res Journal subject: NEOPLASIAS Year: 2017 Document type: Article Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google